These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7195291)

  • 21. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
    Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring uptake of ellipticine and its fluorescence lifetime in relation to the cell cycle phase by flow cytometry.
    Sailer BL; Valdez JG; Steinkamp JA; Darzynkiewicz Z; Crissman HA
    Exp Cell Res; 1997 Oct; 236(1):259-67. PubMed ID: 9344606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
    Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac).
    Hercbergs A; Davis PJ; Davis FB; Ciesielski MJ; Leith JT
    Cell Cycle; 2009 Aug; 8(16):2586-91. PubMed ID: 19597333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of X-ray induced cytotoxicity by neocarzinostatin in asynchronous and synchronous rat 3Y1 fibroblasts.
    Nakamura K
    Fukuoka Igaku Zasshi; 1993 Aug; 84(8):363-7. PubMed ID: 8375797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in survival and potentially lethal damage recovery following periods of high and low metabolic activity in human glioma cells.
    Heller DP; Feeley MM; Raaphorst GP
    Oncol Res; 1993; 5(12):475-82. PubMed ID: 8086669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings of the Symposium on Cell Kinetics and Cancer Chemotherapy (Annapolis, Maryland, November 4-6, 1975): Introduction to session on drug lethality and sublethal damage: cytotoxic damage and repair.
    Elkind MM
    Cancer Treat Rep; 1976 Dec; 60(12):1777-80. PubMed ID: 1026334
    [No Abstract]   [Full Text] [Related]  

  • 30. Modification of radiation sensitivity of cultured cells by pre- and postirradiation incubation with dibutyryl cyclic AMP.
    Kimura H; Yasui T; Aoyama T
    Radiat Res; 1981 Jan; 85(1):207-14. PubMed ID: 6258189
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of radiosensitivity in Chinese hamster lung fibroblasts by cisplatin.
    Akudugu JM; Slabbert JP
    Can J Physiol Pharmacol; 2008 May; 86(5):257-63. PubMed ID: 18432286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
    Kishi S; Goto N; Nakamura T; Ueda T
    Cancer Res; 1999 Jun; 59(11):2629-34. PubMed ID: 10363985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines.
    Herring CJ; Deans B; Elder RH; Rafferty JA; MacKinnon J; Barzilay G; Hickson ID; Hendry JH; Margison GP
    Br J Cancer; 1999 Jun; 80(7):940-5. PubMed ID: 10362100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of DNA repair activity in rat-liver cells exposed to cisplatin.
    Hibino Y; Kamiuchi S; Kusashio E; Sugano N
    Biochem Mol Biol Int; 1996 Apr; 38(5):973-9. PubMed ID: 9132166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.
    Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM
    Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
    J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications.
    Drewinko B; Brown BW; Gottlieb JA
    Cancer Res; 1973 Dec; 33(12):3091-5. PubMed ID: 4760525
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.